Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia. - Wikidata - awgldk - TriplyDB

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia.

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia.

http://www.wikidata.org/entity/Q36597388

about

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation.Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients.NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands.Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML.Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2.Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.

P2860

Q36946572-81D93A0F-0063-4F90-846E-4D2A53F6E96C Q37564774-5BA67E8B-D89E-4E77-9597-E40C76E1D212 Q38651290-94ADC87E-B85E-4A8B-B23B-CE28A2BC42A4 Q38772230-55B9FCA3-FE9E-42D3-AEB2-3AD109E89F88 Q41269711-123202B9-8ABB-4B42-BB83-23937786847A Q41472587-8B960528-610F-43A0-8941-917F7A87805B Q41979268-033DF09B-BCFD-4034-9F9F-48D0E5844821 Q42683573-881077F9-710C-4A41-928F-A87CA003E921 Q47112939-B9A7B366-78A6-4E16-9CFE-7854C9F5453D Q47117842-04D0CF50-EFD4-4E0F-8909-64137BFEE74E Q51600879-D5D65329-310E-4880-AE2A-E6E23001043C Q55397325-C306C792-A9A3-4019-83ED-254843B0323B

P2860

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia.

http://www.wikidata.org/entity/Q36597388

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Role of natural killer cell su ...... apy in acute myeloid leukemia.

@ast

Role of natural killer cell su ...... apy in acute myeloid leukemia.

@en

type

label

Role of natural killer cell su ...... apy in acute myeloid leukemia.

@ast

Role of natural killer cell su ...... apy in acute myeloid leukemia.

@en

prefLabel

Role of natural killer cell su ...... apy in acute myeloid leukemia.

@ast

Role of natural killer cell su ...... apy in acute myeloid leukemia.

@en

P1433

Q36597388-2AB2195B-2780-4068-ADA9-4D83200590BD

P1476

Q36597388-D92A89CC-0D44-4B8D-86D5-6415C2983825

P2093

Q36597388-36F650B7-DCC0-4058-B569-5F221281CEC4

Q36597388-4CBC4311-19FF-4153-8BE4-EBC526FEFF6E

Q36597388-53F44150-DD4E-4CC5-9627-1819F9520F38

Q36597388-5AEADDD9-0E36-4C21-BC52-4A0A3A969EC8

Q36597388-992260FE-DD33-4C08-B777-6E6CF48C4363

Q36597388-E3D3B0C0-B69F-459D-A027-EBCA50698FFE

P2860

Q36597388-00BEE989-929C-4A8A-946B-3EBEC302E220

Q36597388-018F5A0C-7A8C-4BDA-8A9E-F386580C5B77

Q36597388-07E15B9A-ABDD-428C-841A-841603A5A07C

Q36597388-084876B7-027E-4456-AA42-BEAA950997DC

Q36597388-121ABC46-FD6B-4F62-82E4-42C4F2B60616

Q36597388-1BCD0119-3340-4981-BDC0-EDF05BFF1988

Q36597388-1FE9E1BE-1D52-4AA2-90F1-B77EFA775768

Q36597388-20E385A9-4F67-4F30-8812-A21EFAC68974

Q36597388-357C672C-DD97-469B-A20A-DC0C8788E03B

Q36597388-3717609E-52EC-431D-BF06-90F23D927926

P304

Q36597388-456FB41F-4958-4297-BCFA-824316B55BE6

P31

Q36597388-75C0D015-F518-495B-9D08-92BC04D91486

P356

Q36597388-6E0B973D-AE95-485A-AFE0-EF31A81D5C12

P433

Q36597388-A3D0FB56-F3C3-4FF9-A54C-E4E08D3A7E55

P478

Q36597388-660D507E-F44F-41AC-B2B1-870998092564

P50

Q36597388-02A1B6B3-F787-41A1-B125-F8DBCE327880

Q36597388-6B0408B5-D95D-45EA-A779-0F55D4E1483E

Q36597388-DB994750-C8BE-4BBA-B01F-55621A5DCA63

P577

Q36597388-021A8E0B-AB54-4B7B-999C-89BA789553E1

P5875

Q36597388-30A2CCFD-1970-4A73-9F44-4F19EF3A1E89

P698

Q36597388-7077E09B-B814-4DA4-9EDF-8F1DC5DE75F5

P932

Q36597388-A6455EBB-0F52-43B1-97DD-D892783A967A

P356

2162402X.2015.1041701

P1433

P1476

Role of natural killer cell su ...... apy in acute myeloid leukemia.

@en

P2093

Anna Rydström

http://www.w3.org/2001/XMLSchema#string

Harald Anderson

http://www.w3.org/2001/XMLSchema#string

Johan Aurelius

http://www.w3.org/2001/XMLSchema#string

Mats Brune

http://www.w3.org/2001/XMLSchema#string

Rebecca E Riise

http://www.w3.org/2001/XMLSchema#string

Robin Foà

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

Myeloid-derived suppressor cells as regulators of the immune system

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

NK cell recognition

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.

Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites.

P304

e1041701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2015.1041701

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Fredrik B. Thorén

Kristoffer Hellstrand

P577

2015-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276513252

http://www.w3.org/2001/XMLSchema#string

P698

26942055

http://www.w3.org/2001/XMLSchema#string

P932

4760300

http://www.w3.org/2001/XMLSchema#string